Lisa Harding, MD, urges psychiatrists to gather histories, deprescribe safely, and send focused sleep referrals now that orexin agonists have arrived for narcolepsy.
News|Articles|July 11, 2025
Are You Ready for the Southern California Psychiatry Conference?
Author(s)Leah Kuntz
Brush up on your reading before you attend the Southern California Psychiatry Conference!
Related to this article
Real-world data links once-monthly Uzedy to fewer ER visits, better adherence, and lower costs—plus fewer bipolar I relapses when switching from pills.
Experts highlight biomarker-driven schizophrenia care—computational subtypes, muscarinic drugs, sharper negative-symptom scoring, and KCC2 targets—reducing trial-and-error prescribing.
Panelists explain why precision tools lag in schizophrenia care and highlight simple biomarkers, faster deals, and clinician-industry collaboration.
Trending on Psychiatric Times
1
The New, Impending Adult ADHD Guidelines
2
Two New MDD Approvals: 5-HT1A Agonism and Adjunctive Atypical Antipsychotics
3
Olanzapine LAI (Weltruza) Receives FDA Approval for Schizophrenia
4
What Makes Us Human? The Role of Psychiatry and the Future DSM
5